Stock info Alkermes | Filter  Basic-Info

Alkermes

Past year was a negative year for Alkermes investors

The period between December 2015 and December 2016 was a bad period for the investors. The stock lost almost 27 percent. Over the period from December 2011 till December 2016 the stock rose on average 231 percent. Alkermes's revenues between 2011 and 2015 were very volatile and moved between 389,98 million dollars and 628,34 million dollars. Alkermes's net incomes between 2011 and 2015 were very volatile through the time and moved between -45,54 million dollars and -227,16 million dollars.

Alkermes's headquarter is based in Dublin. Alkermes's core business is the pharmaceutical sector. Mr. Richard F. Pops is the CEO of the company. Alkermes' CFO is Mr. James M. Frates. The global pharmaceutical companies gained over the past 10 years on average 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.

The American company didn't pay out any dividends (in the past 5 years).

At the end of 2015 around 1300 thousand people were on Alkermes' payroll.

Healthy financed: not so much debt Alkermes

At the end of 2015 the pharmaceutical company's balance sheet equaled 1,86 billion dollars. 541,46 million dollars (29,18 percent of the total balance sheet) was financed by debt. At the end of 2015 the pharmaceutical company's stock was traded with a price/earnings-ratio -37. So the stock' value was -37 times the 2015' earnings per share. Many analysts say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a growth stock.

At the end of 2015 the pharmaceutical company's market capitalization (the number of shares times the market price) equaled around 11,42 billion dollars. At the end of 2015 the American company had around 150,7 million stocks listed on the exchanges.

At this page you find all Alkermes's financial reports. More information about Alkermes can be found it's website. .